What is Haemonetics's apheresis — total net revenues?

Haemonetics (HAE) reported apheresis — total net revenues of $191.32M in Q2 2026.

What does apheresis — total net revenues mean?

This represents the total gross sales generated by the Apheresis segment, net of returns, allowances, and discounts. It serves as the primary indicator of the segment's market demand and competitive success in the blood and plasma collection space. Growth in this metric is a key driver of the company's overall top-line performance.

Haemonetics (HAE) Apheresis — Total net revenues

Screener

Other segment segments

MedSurg

$148.06M—

Similar metrics at other companies

ACELNet gaming — Total net revenues

$331.43M+9.8%

ACELAmusement — Total net revenues

$5.83M-1.4%

ACELGeorgia — Total net revenues

$6.18M+43.0%

ACELIllinois — Total net revenues

$252.8M+8.3%

ACELLouisiana — Total net revenues

$10.14M+12.4%

ACELManufacturing — Total net revenues

$1.24M-67.9%

Other financials

Income statement

See full

Revenue$339.4M+5.6%

Gross profit$202.8M+5.5%

Operating income$57.5M+6.7%

Net income$33.0M-3.0%

EPS (diluted)$0.72+2.9%

Balance sheet

See full

Cash & equivalents$223.4M-23.7%

Total debt$1.2B-4.1%

Total equity$837.1M-5.1%

Total assets$2.4B-3.9%

Cash flow

See full

Operating cash flow$52.3M+201%

CapEx$7.9M+111%

Free cash flow$44.4M+226%

Valuation

See full

Market cap$3.87B+6.3%

Enterprise value$4.82B+5.4%

P/E25.7×-10.5×

P/S2.9×+0.2×

Profitability

See full

Gross margin59%+2.1pp

Operating margin19%+5.9pp

Net margin13.3%+3.8pp

FCF margin21.5%+7.5pp

Returns & leverage

See full

Return on equity19.3%+5.2pp

Debt / equity1.4×0.0×

Current ratio3.1×+1.4×

Where this comes from

Reported directly by Haemonetics in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax.

The source filing: Haemonetics’s 10-Q, filed August 6, 2026.

Filed: Aug 6, 2026, 6:09 AM EDT
Fiscal quarter: Q1 FY2027
Calendar quarter: Q2 2026
Accession: 0000313143-26-000120

Line item	Three Months Ended / June 27, 2026	Three Months Ended / June 28, 2025
Net revenues:
Apheresis	$191,318	$181,736
MedSurg	148,062	139,658
Total net revenues	$339,380	$321,394
Significant segment expenses and operating performance:
Apheresis
Cost of goods sold	$84,131	$75,865
Selling, general and administrative	44,264	39,880

ITEM 1. FINANCIAL STATEMENTS

FAQ

What is Haemonetics's apheresis — total net revenues?: Haemonetics (HAE) reported apheresis — total net revenues of $191.32M in Q2 2026.
What does apheresis — total net revenues mean?: This represents the total gross sales generated by the Apheresis segment, net of returns, allowances, and discounts. It serves as the primary indicator of the segment's market demand and competitive success in the blood and plasma collection space. Growth in this metric is a key driver of the company's overall top-line performance.